These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8507286)
1. Random drug testing: a commitment to a drug free workplace. Smith NG AAOHN J; 1993 Apr; 41(4):193-4. PubMed ID: 8507286 [No Abstract] [Full Text] [Related]
2. Drugs and alcohol in the workplace. Conry PB AAOHN J; 1991 Oct; 39(10):461-5. PubMed ID: 1930379 [TBL] [Abstract][Full Text] [Related]
3. A new challenge for drug-free workplace programs. DuPont RL; Martin DM; Skipper GE Occup Health Saf; 2012 Feb; 81(2):32, 34. PubMed ID: 22435238 [No Abstract] [Full Text] [Related]
4. Why drugs and safety don't mix. Cholakis P Occup Health Saf; 2006 Aug; 75(8):28, 31-2. PubMed ID: 16944799 [No Abstract] [Full Text] [Related]
5. New solutions for ensuring a drug-free workplace. Current B Occup Health Saf; 2002 Apr; 71(4):34-5. PubMed ID: 11977560 [No Abstract] [Full Text] [Related]
7. Role of occupational health services in workplace drug testing. Lillsunde P; Mukala K; Partinen R; Lamberg M Forensic Sci Int; 2008 Jan; 174(2-3):103-6. PubMed ID: 17467212 [TBL] [Abstract][Full Text] [Related]
8. Linking drug testing to treatment: an idea whose time has come. Thomas SP Issues Ment Health Nurs; 2010 Jun; 31(6):375. PubMed ID: 20450338 [No Abstract] [Full Text] [Related]
10. Finnish guidelines for workplace drug testing. Lillsunde P; Haavanlammi K; Partinen R; Mukala K; Lamberg M Forensic Sci Int; 2008 Jan; 174(2-3):99-102. PubMed ID: 17499950 [TBL] [Abstract][Full Text] [Related]
11. Special report. Drug usage by employees: an update. Hosp Secur Saf Manage; 1992 Jun; 13(2):5-9. PubMed ID: 10171055 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing. Miller TR; Zaloshnja E; Spicer RS Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723 [TBL] [Abstract][Full Text] [Related]
13. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations. Bush DM Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274 [TBL] [Abstract][Full Text] [Related]
14. Drug testing in the workplace. Osterloh J Occup Med; 1990; 5(3):617-32. PubMed ID: 2218805 [TBL] [Abstract][Full Text] [Related]
15. Changing media in workplace programs. Lappe ML Occup Health Saf; 2002 Apr; 71(4):28-32. PubMed ID: 11977559 [No Abstract] [Full Text] [Related]
16. Choosing a drug test panel: concepts and considerations. Sagall R Occup Health Saf; 2005 Apr; 74(4):83-5. PubMed ID: 15915700 [No Abstract] [Full Text] [Related]
17. Workplace drug testing and worker drug use. Carpenter CS Health Serv Res; 2007 Apr; 42(2):795-810. PubMed ID: 17362218 [TBL] [Abstract][Full Text] [Related]
18. Substance abuse in the workplace: epidemiology, effects, and industry response. Bush DM; Autry JH Occup Med; 2002; 17(1):13-25, iii. PubMed ID: 11726333 [TBL] [Abstract][Full Text] [Related]
19. Workplace substance abuse impairment: the occupational health care provider's role. McAndrew KG; McAndrew SJ AAOHN J; 2000 Jan; 48(1):32-45; quiz 46-7. PubMed ID: 15635918 [TBL] [Abstract][Full Text] [Related]
20. Types of drug-testing programmes in the workplace. Mørland J Bull Narc; 1993; 45(2):83-113. PubMed ID: 7920543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]